J. European Academy of Dermatology and Venereology, 4 August 2014
Plos Neglected Tropical Diseases 8(11): e3229 (20 November 2014)
PLoS One. 2012; 7(4): e29656.
Published online 2012 Apr 20. doi: 10.1371/journal.pone.0029656
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
A review of current literature and up date data from the field, April 2015.
This report has been published in part in J Hosp Inf. 2015;90:1-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola+nosocomial+shears
This new online platform brings together key international resources and national policies, strategies, laws and service standards for mental health, substance abuse, general health, disability, human rights and development.
Find out more: http://www.mindbank.info/
Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo.
Thir brochure provides information and advices about the german health system (health insurance, treatment, counseling, offers for sanspapiers) and sexual health (prevention of sexual transmitted diseases including HIV, counseling, treatment, contraception). Attached are adresses from different orga...nizations for more information.
Diese Broschüre bietet Informationen und Tipps zu den Themen Gesundheitssystem in Deutschland (Krankenversicherung, Behandlung, Beratung, Angebote für Menschen ohne Papiere) und sexülle Gesundheit (Schutz vor sexüll übertragbaren Krankheiten einschließlich HIV, Untersuchung, Behandlung, Schwangerschaftsverhütung). - Im Anhang: Adressen von Organisationen für weitere Informationen und Beratung.
more
Bebilderte Informationsblätter in Deutsch-Englisch-Französisch-Polnisch-Russisch-Serbisch-
Albanisch-Türkisch-Arabisch-Farsi-Urdu
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...tivities has been largely guided by small and large pharmaceutical companies according to a variety of parameters, such as perceived/unmet medical need, pressure of investors, market size, scientific discovery potential, and availability of specific technologies. Previous PPLs, issued by the Centers for Disease Control and Prevention.
more